Antal Rohit Desai sold $4.7M of PRCT
director at PROCEPT BioRobotics Corp. 75,000 shares at an average of $62.16, traded Jun 3, 2025, filed Jun 5, 2025.
Score components
- +15RoleDirector
- +25Trade size$4.7M at market
- +10Share of holdings soldSold 46% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -11.0%, 3m -41.1%, 6m -45.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-029800, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 3, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -900 | $58.04 | $52k | 163,463 | Jun 5, 2025 |
| Jun 3, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -1,100 | $59.14 | $65k | 162,363 | Jun 5, 2025 |
| Jun 3, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -9,880 | $60.23 | $595k | 152,483 | Jun 5, 2025 |
| Jun 3, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -11,602 | $61.22 | $710k | 140,881 | Jun 5, 2025 |
| Jun 3, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -1,518 | $61.83 | $94k | 139,363 | Jun 5, 2025 |
| Jun 4, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -16,400 | $60.82 | $998k | 122,963 | Jun 5, 2025 |
| Jun 4, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -8,600 | $61.40 | $528k | 114,363 | Jun 5, 2025 |
| Jun 5, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -700 | $61.85 | $43k | 113,663 | Jun 5, 2025 |
| Jun 5, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -1,706 | $63.07 | $108k | 111,957 | Jun 5, 2025 |
| Jun 5, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -5,946 | $64.19 | $382k | 106,011 | Jun 5, 2025 |
| Jun 5, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -12,548 | $65.09 | $817k | 93,463 | Jun 5, 2025 |
| Jun 5, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -4,000 | $65.94 | $264k | 89,463 | Jun 5, 2025 |
| Jun 5, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -100 | $66.73 | $6,673 | 89,363 | Jun 5, 2025 |
Related signals
Other insiders at PROCEPT BioRobotics Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $6,223 297 shares | -0% | |
| 30Weak | PROCEPT BioRobotics Corp | Barry L Templin EVP, Chief Technology Officer | $7,815 373 shares | -0% | |
| 37Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $7,815 373 shares | -0% | |
| 59Moderate | PRCTbuy PROCEPT BioRobotics Corp | Larry L Wood President, CEO | $498k 23,900 shares | - | |
| 30Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $8,117 285 shares | -0% | |
| 30Weak | PROCEPT BioRobotics Corp | Barry L Templin EVP, Chief Technology Officer | $10k 358 shares | -1% | |
| 37Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $10k 357 shares | -0% | |
| 23Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $8,559 304 shares | -0% | |
| 14Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $139k 5,363 shares | -5% | |
| 30Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $20k 706 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.